Navigation Links
Stereotaxis Reports Record First Quarter Orders
Date:5/6/2008

or $(0.37) per share. This compares to a net loss of $10.5 million, or $(0.31) per share, in the first quarter of 2007. The weighted average shares for the recent first quarter were 36.5 million compared with 34.4 million in the first quarter of last year. The increase in weighted average shares reflected the issuance of 1.9 million shares in a sale of common stock in a registered direct offering completed in March 2007.

Cash and investments at March 31, 2008 totaled $11.4 million, compared to $23.6 million at December 31, 2007.

Conference Call Information

The Company has scheduled a conference call for 8:30 a.m. Eastern Standard Time today to discuss its financial results for the first quarter. To access the conference call, please dial (866) 249-6463. International participants can call (303) 262-2175. An audio replay of the call will be available for seven 7 days following the call at (800) 405-2236 for U.S. callers or (303) 590-3000 for those calling outside the U.S. The password required to access the replay is 11113274#. The call will also be available on the Internet live and for 90 days thereafter at the following URL: http://www.videonewswire.com/event.asp?id=47952

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduc
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Stereotaxis to Present at the Deutsche Bank 33rd Annual Health Care Conference
2. Stereotaxis Niobe Magnetic Navigation Systems Perform Approximately 15,000 Cases
3. Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe
4. Stereotaxis Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
5. Stereotaxis to Present at the Deutsche Bank Small- and Mid-Cap Growth Conference
6. Stereotaxis Receives $20 Million in Additional Loan Commitments
7. Stereotaxis Provides Fourth Quarter 2007 Revenue Outlook
8. Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System
9. Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System
10. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
11. Kaiser Foundation Health Plan and Hospitals Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... -- U.S. heart experts recommend doctors use a 14-point ... people for underlying heart disease that could result in ... the American College of Cardiology said in a joint ... history along with a physical examination can help identify ... risks for sudden cardiac death. The statement, ...
(Date:9/15/2014)... 2014 “Canada Gynecological Devices Market ... the Canada Gynecological Devices market. The report provides ... units) and average prices (in US dollars) within ... Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical ... Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation ...
(Date:9/15/2014)... HealthDay Reporter MONDAY, Sept. ... twice as often as they,re actually needed for children ... More than 11 million antibiotic prescriptions written each ... to researchers from University of Washington and Seattle Children,s ... eradicate children,s viral illnesses, researchers said, but supports the ...
(Date:9/15/2014)... 15, 2014 As Colorado's historic ... its first full year, there are a variety ... in the evolution of its marketing and branding. ... taken by Denver's Kindman, one of the state's ... , Kindman has pioneered the first-ever branded and ...
(Date:9/15/2014)... Physicians and clinicians from around ... at the Lowes Coronado Bay Resort for the ... . This CME accredited medical conference ... healthcare professionals—about the nutritional science that overwhelmingly supports ... its proven ability to prevent, suspend and, often, ...
Breaking Medicine News(10 mins):Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 3Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 2Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 3Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 2Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 3
... It,s long been known that obesity increases diabetes risk, but ... someone carries -- and how long it,s carried -- can ... the growing number of obese children and teens who will ... researchers from the University of Michigan Health System warn in ...
... 2011) More part-time employment for surgeons, particularly retiring older ... families, may considerably reduce the surgeon shortage in the United ... September issue of the Journal of the American College ... gaining popularity among Generation X (currently ages 30 through early ...
... HealthDay Reporter , SUNDAY, Sept. 11 (HealthDay News) -- ... of Pearl Harbor still packs a psychological punch for many ... serves as the moment when a stunned young country shed ... stage with the now-iconic can-do bravado of the "Greatest Generation." ...
... The Journal of Emergency Medical Services (JEMS) today announces ... featuring first-person accounts of responders who were thrust into ... when terrorists invaded their response districts and their ... responders throughout the world, think, train, respond and live ...
... FRIDAY, Sept. 9 (HealthDay News) -- Almost half of all ... the months following the 9/11 terrorist attacks still struggle with ... Harris Interactive/HealthDay poll found. The most common ... 24 percent of those still affected, and anxiety, by 13 ...
... , ROCHESTER, Minn. -- Mayo Clinic researchers have developed a ... to combat human HIV/AIDS and other diseases. The goal is ... virus. The findings -- called fascinating and landmark by one ... Nature Methods . Feline immunodeficiency ...
Cached Medicine News:Health News:Lifetime 'Dose' of Excess Weight Linked to Diabetes Risk 2Health News:Allowing part-time surgeons may help address workforce shortage 2Health News:9/11 Left Permanent Scars on the American Psyche 2Health News:9/11 Left Permanent Scars on the American Psyche 3Health News:9/11 Left Permanent Scars on the American Psyche 4Health News:9/11 Left Permanent Scars on the American Psyche 5Health News:9/11 Left Permanent Scars on the American Psyche 6Health News:Out of the darkness 2Health News:For Many Americans, 9/11 Worries Still Dominate 2Health News:For Many Americans, 9/11 Worries Still Dominate 3Health News:Mayo Clinic teams with glowing cats against AIDS, other diseases 2
(Date:9/15/2014)... SINGAPORE , Sept. 15, 2014  Catalist-listed QT ... "the Group"), a developer and manufacturer of minimally invasive ... pleased to announce that the Group has enrolled the ... Germany . Multiple patients have already been ... , at Auckland City Hospital, in Auckland, ...
(Date:9/15/2014)... Sept. 15, 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... paid the September 12, 2014, regular quarterly dividend payment of ... PDL as of September 5, 2014, the record date. ... manages a portfolio of patents and royalty assets, consisting ... and license agreements with various biotechnology and pharmaceutical companies. ...
(Date:9/15/2014)... , Sept. 15, 2014 Research and ... "Closed Drug Transfer Systems to 2020" report to ... deemed hazardous to humans has been receiving increasing amounts ... these substances become more clearly understood. For caregivers and ... forefront of attempts to mitigate exposure to cytotoxic drugs ...
Breaking Medicine Technology:First European Patients Enrolled in QT Vascular's ENDURE Trial 2First European Patients Enrolled in QT Vascular's ENDURE Trial 3First European Patients Enrolled in QT Vascular's ENDURE Trial 4First European Patients Enrolled in QT Vascular's ENDURE Trial 5PDL BioPharma Completes Regular Quarterly Dividend Payment 2Closed Drug Transfer Systems to 2020 2Closed Drug Transfer Systems to 2020 3
... Doubled Time to Progression and Overall Response Rate as ... in Patients with 2nd or 3rd Line Metastatic Colon ... KERX ) today announced data on the ... cancer, in combination with capecitabine as a treatment for ...
... increase the risk of breast cancer recurrence , ... found that taking tamoxifen with certain antidepressants more than ... taking both medications. The antidepressants inhibit an enzyme, CYP2D6, ... ) , , The study ...
Cached Medicine Technology:Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 2Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 3Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 4Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 5Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 6New Research Shows Antidepressants May Thwart Breast Cancer Treatment 2New Research Shows Antidepressants May Thwart Breast Cancer Treatment 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: